<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39">
 <label>39</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Aghajanian</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Soignet</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Dizon</surname>
    <given-names>D. S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies</article-title>
  <source>
   <italic toggle="yes">Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res.</italic>
  </source>
  <year>2002</year>
  <volume>8</volume>
  <issue>8</issue>
  <fpage>2505</fpage>
  <lpage>2511</lpage>
 </element-citation>
</ref>
